IBL HealthCare Limited IBLHL
Rs 48.05
Vol69,069Updated12:2719 Aug 2026
01—At a Glance
The headline take on IBLHL — valuation, income, returns, and efficiency
Consolidated snapshot
02—Price & Performance
Closing prices across timeframes, returns, and range context
IBLHL — Price History
Daily closing series · toggle period below
03—Key Metrics
Valuation, profitability, structure, and risk in one grid
04—Dividend History & Yield
Payout track record, yield trend, and upcoming distribution
IBLHL has no cash dividend in the trailing 12 months. Its most recent payout was a 15% bonus issue, announced 01 Oct 2025 with book closure from 09 Oct 2025. Annual dividend-per-share history back to 2016 is charted below.
Latest Payout
Dividend Per Share Trend
Payout History
Source: PSX company payouts
| Announced | For Period | Type | Amount | Book Closure |
|---|---|---|---|---|
| 01 Oct 2025 | 30 Jun 2025 (YR) | Bonus | 15% | 09 Oct 2025 – 09 Oct 2025 |
05—Financials & Earnings
Income, balance sheet, and key ratios from published accounts
IBLHL's market capitalisation stands at Rs 4.77B as of 18 Aug 2026 — down 21.0% over the past 12 months (from Rs 6.04B).
Financial Statements
How IBLHL's income and balance sheet have evolved
| PKR Millions | Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Net Sales / Revenue | 1,213 | 971 | 1,121 | 1,178 | 948 | 1,118 | 1,079 | 421 | |
| Cost of Sales | 770 | 569 | 721 | 719 | 635 | 783 | 739 | 577 | |
| Gross Profit | 443 | 402 | 400 | 459 | 313 | 335 | 340 | -156 | |
| Administrative Expenses | 55 | 47 | 40 | 42 | 34 | 34 | 34 | 27 | |
| Operating Profit | 143 | 82 | 130 | 141 | 82 | 100 | 121 | -143 | |
| EBITDA | 146 | 86 | 132 | 145 | 83 | 102 | 122 | -141 | |
| Other Income | 2 | 5 | 2 | 2 | -2 | 2 | -2 | -1 | |
| Financial Charges | 11 | 12 | 9 | 12 | 15 | 21 | 12 | 13 | |
| Profit Before Tax | 133 | 75 | 123 | 124 | 65 | 81 | 107 | -167 | |
| Taxation | 71 | 39 | 53 | 51 | 29 | 41 | 47 | 8 | |
| Profit After Tax | 62 | 36 | 70 | 73 | 35 | 40 | 60 | -175 | |
| EPS - Basic (Rs) | Rs 0.63 | Rs 0.36 | Rs 0.81 | Rs 0.91 | Rs 0.41 | Rs 0.41 | Rs 0.70 | Rs -2.03 |
Showing 8 of 8 quarters · scroll horizontally to see more periods.
All figures in PKR millions from published accounts.
Profitability & Returns
Margins, returns on capital, and earnings per share
Latest · Mar-26
| Ratio | Value |
|---|---|
| Net profit margin | 5.1% |
| Gross profit margin | 36.5% |
| EBITDA margin | 12.0% |
| EBIT margin | 11.8% |
Net profit margin
Net profit ÷ revenue · %
Financial Health
Coverage, leverage, and the strength of the balance sheet
Latest · Mar-26
| Ratio | Value |
|---|---|
| Current ratio | 2.01 |
| Quick ratio | 1.32 |
| Cash ratio | 0.06 |
| Asset turnover | 0.28x |
| Effective tax rate | 53.4% |
Current ratio
Current assets ÷ current liabilities
Market cap trajectory
Close × current shares outstanding · current Rs 4.77B
Valuation & Capital Returns
What the market is paying for IBLHL, and what it returns to shareholders
Latest · Mar-26
| Ratio | Value |
|---|---|
| Price to earnings | 62.10x |
| Price to book | 1.55x |
| EV / EBITDA | 28.74x |
| Price to sales | 3.18x |
Price to earnings
Period-end price ÷ EPS · times
06—Technical Analysis
Trading signal, moving averages, momentum, and key levels
10-day SMA (Rs 49.27) is below the 30-day SMA (Rs 50.60). RSI at 42 sits in the neutral band.
Moving AverageThe average close over a set window (10/30/200 days) — smooths daily noise to reveal the trend.Read the full guide →
| Period | Value | vs Current | Position |
|---|---|---|---|
| SMA 10 | Rs 49.27 | +2.53% | Below |
| SMA 30 | Rs 50.60 | +5.30% | Below |
| SMA 60 | Rs 50.86 | +5.85% | Below |
| SMA 200 | Rs 52.74 | +9.77% | Below |
At 42, momentum sits within the neutral band (30–70), suggesting balanced buying and selling pressure.
- MACD-0.69
- Signal-0.71
- Histogram+0.01
07—Leverage Insights
MTS, margin financing, futures open interest, and combined exposure
Leverage Composition
MTS · MFS stacked over the selected window
No blank sales
No net blank (short) sales reported for IBLHL on the latest PSX DFC report.
08—Settlement Insights
UIN-wise settlement concentration and price context
Metrics and charts over the selected trailing window
Settlement % Trajectory
Solid = UIN settlement % · Dashed = 14-session EMA
As of 18 Aug 2026
Price vs Settlement
Close price (left axis) · UIN settlement % (right axis)
10—About the Company
Business description, governance, and corporate information
IBL HealthCare Limited was incorporated in Pakistan under the repealed Companies Ordinance, 1984 (now the Companies Act, 2017) as a private limited company on July 14, 1997. In November 2008, the Company was converted into public limited company. The principal activities of the Company include marketing, selling and distribution of healthcare products.
Corporate Information
- RegistrarCenteral Depository Co of Pakistan. CDC House 99 B, Block B S.M.C.H.S, Main Shahrah e Faisal Karachi.
- AuditorA.F.Fergusons & Co, Chartered Accountants
- Websitewww.iblhc.com
- Address2nd Floor, One IBL Centre, Block 7&8, DMCHS Tipu Sultan Road, Off: Shahrah-e-Faisal, Karachi
- SectorPharmaceuticals
- Financial Year EndJune
Key People
| Name | Role |
|---|---|
SKSheraz Khan | CEO |
MZMufti Zia ul Islam | Chairperson |
HMHussain Murtaza | Company Secretary |
Reports & Filings
- Quarterly Report — 31 Mar 2026PDF
- Quarterly Report — 31 Dec 2025PDF
- Quarterly Report — 30 Sept 2025PDF
- Quarterly Report — 31 Mar 2025PDF
- Annual Report FY2025PDF
- Quarterly Report — 31 Dec 2024PDF
- Quarterly Report — 30 Sept 2024PDF
- Quarterly Report — 31 Mar 2024PDF
Sourced from official PSX financial-report submissions.
11—Recent Announcements
Latest company filings as reported on PSX
Filings and disclosures from the PSX announcement feed
- 12 Aug 2026General Meeting
- 05 Aug 2026Management Change
- 03 Aug 2026Financial ResultsBoard Meeting Other Than Financial Results
- 27 Jul 2026Financial ResultsBoard Meeting Other Than Financial Results
- 22 Jul 2026General Meeting
- 19 Jun 2026OthersChange of Chairman
- 05 Jun 2026OthersChange of Director
- 30 Apr 2026Financial Results
12—Peers in Pharmaceuticals
How the cohort is moving — same-sector stocks by market cap
IBLHL vs Pharmaceuticals sector median
| Metric | IBLHL | Sector median |
|---|---|---|
| P/E RatioShare price ÷ earnings per share — the price you pay for each rupee of annual profit. Compare within a sector.Read the full guide → | 19.9x | 15.3x |
| Dividend YieldTrailing-12-month cash dividends ÷ share price. A high yield can signal income — or a falling price.Read the full guide → | 0.0% | 4.1% |
| Return on EquityNet profit ÷ shareholders' equity — how hard the company works each rupee investors have put in.Read the full guide → | 9.4% | 22.3% |
| 1-Year Return | -21.2% | -15.9% |
| Market CapitalisationShare price × total shares — the company's full market value, and the basis for index weightings.Read the full guide → | Rs 4.77B | Rs 27.59B |
Pharmaceuticals · sector heat
13—Frequently Asked Questions
The most common questions investors ask about IBLHL
Frequently Asked Questions
IBLHL is trading at Rs 48.05, down 0.78% on the day, within a 52-week range of Rs 36.00–85.82, from the 15-minute snapshot taken at 12:30 PKT. Prices on this page refresh every 15 minutes during market hours; log in to BSL for live quotes.
IBL HealthCare Limited was incorporated in Pakistan under the repealed Companies Ordinance, 1984 (now the Companies Act, 2017) as a private limited company on July 14, 1997. See About the Company on this page for the full profile, management, and corporate information.
IBLHL has not declared a cash dividend in the recent PSX record — some companies reinvest earnings instead; see the Financials section. For income ideas, browse the highest dividend yield stocks on PSX.
No upcoming payout is announced yet. The most recent was a 15% bonus issue with book closure from 09 Oct 2025. New announcements appear on this page and on the PSX ex-dates calendar.
Yes — IBL HealthCare Limited is on the PSX's Shariah-compliant (KMI All Shares) list. Browse all Shariah-compliant PSX stocks.
IBLHL trades at 19.9x earnings against a Pharmaceuticals median of 15.3x. The full comparison table and peer list are in the Peers section, or explore the Pharmaceuticals sector page.
Annual reports for FY2025 are linked under Reports & Filings in the About section of this page, sourced from official PSX submissions.
Open a BSL trading account, fund it, and place your IBLHL order on the Pakistan Stock Exchange — account opening takes minutes online, with PSX execution, research, and concierge support included.
Quotes and metrics refresh on a regular cadence through the trading day and after the close. For streaming real-time PSX prices and order placement, log in to your BSL account.
Ready to invest in IBLHL?
Open a BSL trading account in under 10 minutes
Buy and sell IBLHL and every other PSX-listed stock with low commissions, real-time data, and a concierge research desk backing every trade.